Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1441 to 1448 of 1448 entries
Sorted by: Best Match Show Resources per page
Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator.

Acta ophthalmologica

Caporossi T, Bacherini D, Governatori L, Oliverio L, Di Leo L, Tartaro R, Rizzo S.
PMID: 34609787
Acta Ophthalmol. 2021 Oct 05; doi: 10.1111/aos.15045. Epub 2021 Oct 05.

PURPOSE: Macular neovascularization (MNV) can complicate age-related macular degeneration (AMD) and lead to severe visual acuity reduction. Massive submacular haemorrhage (SMH) is a sight-threatening complication of MNV and a challenge in the management of complications related to MNV in...

Cite
Caporossi T, Bacherini D, Governatori L, et al. Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator. Acta Ophthalmol. 2021;doi: 10.1111/aos.15045.
Caporossi, T., Bacherini, D., Governatori, L., Oliverio, L., Di Leo, L., Tartaro, R., & Rizzo, S. (2021). Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator. Acta ophthalmologica, . https://doi.org/10.1111/aos.15045
Caporossi, Tomaso, et al. "Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator." Acta ophthalmologica vol. (2021). doi: https://doi.org/10.1111/aos.15045
Caporossi T, Bacherini D, Governatori L, Oliverio L, Di Leo L, Tartaro R, Rizzo S. Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator. Acta Ophthalmol. 2021 Oct 05; doi: 10.1111/aos.15045. Epub 2021 Oct 05. PMID: 34609787.
Copy Download .nbib Format: NLM
The Japan Neurosurgical Database: Statistics Update 2018 and 2019.

Neurologia medico-chirurgica

Iihara K, Saito N, Suzuki M, Date I, Fujii Y, Houkin K, Inoue T, Iwama T, Kawamata T, Kim P, Kinouchi H, Kishima H, Kohmura E, Kurisu K, Maruyama K, Matsumaru Y, Mikuni N, Miyamoto S, Morita A, Nakase H, Narita Y, Nishikawa R, Nozaki K, Ogasawara K, Ohata K, Sakai N, Sakamoto H, Shiokawa Y, Takahashi JC, Ueki K, Wakabayashi T, Yoshimoto K, Arai H, Tominaga T.
PMID: 34732592
Neurol Med Chir (Tokyo). 2021 Dec 15;61(12):675-710. doi: 10.2176/nmc.st.2021-0254. Epub 2021 Nov 03.

Each year, the Japan Neurosurgical Society (JNS) reports up-to-date statistics from the Japan Neurosurgical Database regarding case volume, patient demographics, and in-hospital outcomes of the overall cohort and neurosurgical subgroup according to the major classifications of main diagnosis. We...

Cite
Iihara K, Saito N, Suzuki M, et al. The Japan Neurosurgical Database: Statistics Update 2018 and 2019. Neurol Med Chir (Tokyo). 2021;61(12):675-710doi: 10.2176/nmc.st.2021-0254.
Iihara, K., Saito, N., Suzuki, M., Date, I., Fujii, Y., Houkin, K., Inoue, T., Iwama, T., Kawamata, T., Kim, P., Kinouchi, H., Kishima, H., Kohmura, E., Kurisu, K., Maruyama, K., Matsumaru, Y., Mikuni, N., Miyamoto, S., Morita, A., Nakase, H., Narita, Y., Nishikawa, R., Nozaki, K., Ogasawara, K., Ohata, K., Sakai, N., Sakamoto, H., Shiokawa, Y., Takahashi, J. C., Ueki, K., Wakabayashi, T., Yoshimoto, K., Arai, H., Tominaga, T. (2021). The Japan Neurosurgical Database: Statistics Update 2018 and 2019. Neurologia medico-chirurgica, 61(12), 675-710. https://doi.org/10.2176/nmc.st.2021-0254
Iihara, Koji, et al. "The Japan Neurosurgical Database: Statistics Update 2018 and 2019." Neurologia medico-chirurgica vol. 61,12 (2021): 675-710. doi: https://doi.org/10.2176/nmc.st.2021-0254
Iihara K, Saito N, Suzuki M, Date I, Fujii Y, Houkin K, Inoue T, Iwama T, Kawamata T, Kim P, Kinouchi H, Kishima H, Kohmura E, Kurisu K, Maruyama K, Matsumaru Y, Mikuni N, Miyamoto S, Morita A, Nakase H, Narita Y, Nishikawa R, Nozaki K, Ogasawara K, Ohata K, Sakai N, Sakamoto H, Shiokawa Y, Takahashi JC, Ueki K, Wakabayashi T, Yoshimoto K, Arai H, Tominaga T. The Japan Neurosurgical Database: Statistics Update 2018 and 2019. Neurol Med Chir (Tokyo). 2021 Dec 15;61(12):675-710. doi: 10.2176/nmc.st.2021-0254. Epub 2021 Nov 03. PMID: 34732592; PMCID: PMC8666296.
Copy Download .nbib Format: NLM
Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave.

International journal of laboratory hematology

Evrard J, Maloteau V, Dogné JM, Douxfils J.
PMID: 34613661
Int J Lab Hematol. 2021 Oct 05; doi: 10.1111/ijlh.13723. Epub 2021 Oct 05.

No abstract available.

Cite
Evrard J, Maloteau V, Dogné JM, et al. Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave. Int J Lab Hematol. 2021;doi: 10.1111/ijlh.13723.
Evrard, J., Maloteau, V., Dogné, J. M., & Douxfils, J. (2021). Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave. International journal of laboratory hematology, . https://doi.org/10.1111/ijlh.13723
Evrard, Jonathan, et al. "Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave." International journal of laboratory hematology vol. (2021). doi: https://doi.org/10.1111/ijlh.13723
Evrard J, Maloteau V, Dogné JM, Douxfils J. Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave. Int J Lab Hematol. 2021 Oct 05; doi: 10.1111/ijlh.13723. Epub 2021 Oct 05. PMID: 34613661.
Copy Download .nbib Format: NLM
Deficiency in Neuroserpin Exacerbates CoCl.

Frontiers in pharmacology

Han S, Zhang D, Dong Q, Wang X, Wang L.
PMID: 33737878
Front Pharmacol. 2021 Mar 02;12:632662. doi: 10.3389/fphar.2021.632662. eCollection 2021.

Protective strategy against hypoxic-ischemic (H/I) induced injury has been intensively discussed. Neuroserpin, an inhibitor for tissue plasminogen activator (tPA), has been proved a vital neuroprotective agent in cerebral ischemia mouse model and oxygen-glucose deprivation and reoxygenation (OGD/R) cell model....

Cite
Han S, Zhang D, Dong Q, et al. Deficiency in Neuroserpin Exacerbates CoCl. Front Pharmacol. 2021;12:632662doi: 10.3389/fphar.2021.632662.
Han, S., Zhang, D., Dong, Q., Wang, X., & Wang, L. (2021). Deficiency in Neuroserpin Exacerbates CoCl. Frontiers in pharmacology, 12632662. https://doi.org/10.3389/fphar.2021.632662
Han, Sha, et al. "Deficiency in Neuroserpin Exacerbates CoCl." Frontiers in pharmacology vol. 12 (2021): 632662. doi: https://doi.org/10.3389/fphar.2021.632662
Han S, Zhang D, Dong Q, Wang X, Wang L. Deficiency in Neuroserpin Exacerbates CoCl. Front Pharmacol. 2021 Mar 02;12:632662. doi: 10.3389/fphar.2021.632662. eCollection 2021. PMID: 33737878; PMCID: PMC7960655.
Copy Download .nbib Format: NLM
The effect of intravitreal recombinant tissue plasminogen activator injection on diabetic tractional fibrovascular membranes: Proposed criteria using optical coherence tomography.

European journal of ophthalmology

Ghasemi Falavarjani K, Anvari P, Dehghan Niri M, Molaei S, Abdi F, Shad E, Kazemi P, Sadda SR.
PMID: 33653173
Eur J Ophthalmol. 2021 Mar 02;1120672121998224. doi: 10.1177/1120672121998224. Epub 2021 Mar 02.

PURPOSE: To evaluate the effect of intravitreal recombinant tissue plasminogen activator (tPA) on diabetic tractional fibrovascular membranes (FVM) using proposed optical coherence tomography (OCT) criteria.METHODS: This prospective, interventional case series enrolled eyes with tractional retinal detachment who were candidates...

Cite
Ghasemi Falavarjani K, Anvari P, Dehghan Niri M, et al. The effect of intravitreal recombinant tissue plasminogen activator injection on diabetic tractional fibrovascular membranes: Proposed criteria using optical coherence tomography. Eur J Ophthalmol. 2021;1120672121998224doi: 10.1177/1120672121998224.
Ghasemi Falavarjani, K., Anvari, P., Dehghan Niri, M., Molaei, S., Abdi, F., Shad, E., Kazemi, P., & Sadda, S. R. (2021). The effect of intravitreal recombinant tissue plasminogen activator injection on diabetic tractional fibrovascular membranes: Proposed criteria using optical coherence tomography. European journal of ophthalmology, 1120672121998224. https://doi.org/10.1177/1120672121998224
Ghasemi Falavarjani, Khalil, et al. "The effect of intravitreal recombinant tissue plasminogen activator injection on diabetic tractional fibrovascular membranes: Proposed criteria using optical coherence tomography." European journal of ophthalmology vol. (2021): 1120672121998224. doi: https://doi.org/10.1177/1120672121998224
Ghasemi Falavarjani K, Anvari P, Dehghan Niri M, Molaei S, Abdi F, Shad E, Kazemi P, Sadda SR. The effect of intravitreal recombinant tissue plasminogen activator injection on diabetic tractional fibrovascular membranes: Proposed criteria using optical coherence tomography. Eur J Ophthalmol. 2021 Mar 02;1120672121998224. doi: 10.1177/1120672121998224. Epub 2021 Mar 02. PMID: 33653173.
Copy Download .nbib Format: NLM
Community Intent to Activate Emergency Medical Services May Be Associated with Regional tPA Treatment.

Cerebrovascular diseases (Basel, Switzerland)

Springer MV, Bi R, Skolarus LE, Lin CC, Burke JF.
PMID: 34515063
Cerebrovasc Dis. 2021 Sep 07;1-7. doi: 10.1159/000518729. Epub 2021 Sep 07.

INTRODUCTION: Acute stroke treatments are underutilized in the USA. Enhancing stroke preparedness, the recognition of stroke symptoms, and intent to call emergency medical services (EMS) could reduce delay in hospital arrival thereby increasing eligibility for time-sensitive stroke treatments. Whether...

Cite
Springer MV, Bi R, Skolarus LE, et al. Community Intent to Activate Emergency Medical Services May Be Associated with Regional tPA Treatment. Cerebrovasc Dis. 2021;1-7doi: 10.1159/000518729.
Springer, M. V., Bi, R., Skolarus, L. E., Lin, C. C., & Burke, J. F. (2021). Community Intent to Activate Emergency Medical Services May Be Associated with Regional tPA Treatment. Cerebrovascular diseases (Basel, Switzerland), 1-7. https://doi.org/10.1159/000518729
Springer, Mellanie V, et al. "Community Intent to Activate Emergency Medical Services May Be Associated with Regional tPA Treatment." Cerebrovascular diseases (Basel, Switzerland) vol. (2021): 1-7. doi: https://doi.org/10.1159/000518729
Springer MV, Bi R, Skolarus LE, Lin CC, Burke JF. Community Intent to Activate Emergency Medical Services May Be Associated with Regional tPA Treatment. Cerebrovasc Dis. 2021 Sep 07;1-7. doi: 10.1159/000518729. Epub 2021 Sep 07. PMID: 34515063.
Copy Download .nbib Format: NLM
Thrombolytic Refusal Over Telestroke.

Neurology. Clinical practice

Zha A, Rosero A, Malazarte R, Bozorgui S, Ankrom C, Zhu L, Joseph M, Trevino A, Cossey TD, Savitz S, Wu TC, Jagolino-Cole A.
PMID: 34484903
Neurol Clin Pract. 2021 Jun;11(3):e287-e293. doi: 10.1212/CPJ.0000000000000975.

BACKGROUND: Tissue plasminogen activator (tPA) refusal is 4%-6% for acute ischemic stroke (AIS) in the emergency department. Telestroke (TS) has increased the use of tPA for AIS but is accompanied by barriers in communication that can affect tPA consent....

Cite
Zha A, Rosero A, Malazarte R, et al. Thrombolytic Refusal Over Telestroke. Neurol Clin Pract. 2021;11(3):e287-e293doi: 10.1212/CPJ.0000000000000975.
Zha, A., Rosero, A., Malazarte, R., Bozorgui, S., Ankrom, C., Zhu, L., Joseph, M., Trevino, A., Cossey, T. D., Savitz, S., Wu, T. C., & Jagolino-Cole, A. (2021). Thrombolytic Refusal Over Telestroke. Neurology. Clinical practice, 11(3), e287-e293. https://doi.org/10.1212/CPJ.0000000000000975
Zha, Alicia, et al. "Thrombolytic Refusal Over Telestroke." Neurology. Clinical practice vol. 11,3 (2021): e287-e293. doi: https://doi.org/10.1212/CPJ.0000000000000975
Zha A, Rosero A, Malazarte R, Bozorgui S, Ankrom C, Zhu L, Joseph M, Trevino A, Cossey TD, Savitz S, Wu TC, Jagolino-Cole A. Thrombolytic Refusal Over Telestroke. Neurol Clin Pract. 2021 Jun;11(3):e287-e293. doi: 10.1212/CPJ.0000000000000975. PMID: 34484903; PMCID: PMC8382361.
Copy Download .nbib Format: NLM
Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Chen Y, Nguyen TN, Wellington J, Mofatteh M, Yao W, Hu Z, Kuang Q, Wu W, Wang X, Sun Y, Ouyang K, Xu J, Huang W, Yang S.
PMID: 34735901
J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106179. doi: 10.1016/j.jstrokecerebrovasdis.2021.106179. Epub 2021 Oct 20.

OBJECTIVES: This study aims to evaluate shortening door-to-needle time of intravenous recombinant tissue plasminogen activator of acute ischemic stroke patients by multidisciplinary collaboration and workflow optimization based on our hospital resources.MATERIALS AND METHODS: We included patients undergoing thrombolysis with...

Cite
Chen Y, Nguyen TN, Wellington J, et al. Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic. J Stroke Cerebrovasc Dis. 2021;31(1):106179doi: 10.1016/j.jstrokecerebrovasdis.2021.106179.
Chen, Y., Nguyen, T. N., Wellington, J., Mofatteh, M., Yao, W., Hu, Z., Kuang, Q., Wu, W., Wang, X., Sun, Y., Ouyang, K., Xu, J., Huang, W., & Yang, S. (2022). Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 31(1), 106179. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106179
Chen, Yimin, et al. "Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic." Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association vol. 31,1 (2022): 106179. doi: https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106179
Chen Y, Nguyen TN, Wellington J, Mofatteh M, Yao W, Hu Z, Kuang Q, Wu W, Wang X, Sun Y, Ouyang K, Xu J, Huang W, Yang S. Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic. J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106179. doi: 10.1016/j.jstrokecerebrovasdis.2021.106179. Epub 2021 Oct 20. PMID: 34735901; PMCID: PMC8526426.
Copy Download .nbib Format: NLM
Showing 1441 to 1448 of 1448 entries